"Administration of ""active"" chondroitin sulfate A and ""active"" chondroitin sulfate C or mixtures thereof to mammals including humans"
US4640912A · kind A · utility
Inventor
Key dates
| Filing date | Jun 9, 1983 |
| Grant date | Feb 3, 1987 |
| Priority date | — |
| Expiry date | Jun 9, 2003 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The administration of "active" chondroitin sulfate A (CSA), "active" chondroitin sulfate C (CSC), or mixtures thereof to mammals including humans suffering from cancer, bacterial infections, trauma, irritation, placement of foreign objects, tubes or instruments, or damage of the upper or lower urinary tract, and related transitional cell surfaces to prevent cancer cell implantation or adherence, bacterial infestation or adherence, trauma, irritation, or damage from placement of foreign objects, tubes or instruments in the kidney, renal pelvis, ureter, bladder, urethra and related transitional cell surfaces by the irrigation of said surfaces and/or tubes and instruments with a solution of said drugs or mixtures thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.